Pages that link to "Q26822749"
Jump to navigation
Jump to search
The following pages link to Quantitative approaches of dynamic FDG-PET and PET/CT studies (dPET/CT) for the evaluation of oncological patients (Q26822749):
Displaying 22 items.
- Lung cancer-a fractal viewpoint (Q27310294) (← links)
- Combined use of (18)F-FDG and (18)F-FMISO in unresectable non-small cell lung cancer patients planned for radiotherapy: a dynamic PET/CT study (Q35402102) (← links)
- The contribution of physics to Nuclear Medicine: physicians' perspective on future directions (Q35821199) (← links)
- Kinetic Modeling and Graphical Analysis of 18F-Fluoromethylcholine (FCho), 18F-Fluoroethyltyrosine (FET) and 18F-Fluorodeoxyglucose (FDG) PET for the Fiscrimination between High-Grade Glioma and Radiation Necrosis in Rats (Q36112565) (← links)
- Optimal Scan Time of 18F-FDG PET in Identifying Therapeutic Efficacy Secondary to Radiofrequency Ablation of Lung Cancer: Case Report (Q36194533) (← links)
- Dynamic (18)F-fluorodeoxyglucose positron emission tomography/CT in hibernoma: Enhanced tracer uptake mimicking liposarcoma. (Q37417787) (← links)
- Vision 20/20: Positron emission tomography in radiation therapy planning, delivery, and monitoring (Q38657514) (← links)
- Quantitative analysis of 18F-NaF dynamic PET/CT cannot differentiate malignant from benign lesions in multiple myeloma (Q41180773) (← links)
- Quantitative graphical analysis of simultaneous dynamic PET/MRI for assessment of prostate cancer. (Q41548893) (← links)
- High-resolution dynamic imaging and quantitative analysis of lung cancer xenografts in nude mice using clinical PET/CT. (Q41592912) (← links)
- (68)Ga-PSMA-11 dynamic PET/CT imaging in biochemical relapse of prostate cancer. (Q52985772) (← links)
- [PET-CT for nuclear medicine diagnostics of multiple myeloma]. (Q53063973) (← links)
- Prognostic superiority of the National Comprehensive Cancer Network International Prognostic Index over pretreatment whole-body volumetric-metabolic FDG-PET/CT metrics in diffuse large B-cell lymphoma. (Q53082946) (← links)
- Metabolic subtyping of pheochromocytoma and paraganglioma by F-FDG pharmacokinetics using dynamic PET/CT scanning (Q58566659) (← links)
- PET/CT studies of multiple myeloma using 18 F-FDG and 18 F-NaF: comparison of distribution patterns and tracers’ pharmacokinetics (Q60652348) (← links)
- Bedeutung der PET für die Chirurgie des gastrointestinalen Stromatumors (Q60652350) (← links)
- [Principles of PET] (Q88417295) (← links)
- Quantitative Analysis of Heterogeneous [18F]FDG Static (SUV) vs. Patlak (Ki) Whole-body PET Imaging Using Different Segmentation Methods: a Simulation Study (Q89338993) (← links)
- How Long of a Dynamic 3'-Deoxy-3'-[18F]fluorothymidine ([18F]FLT) PET Acquisition Is Needed for Robust Kinetic Analysis in Breast Cancer? (Q89483641) (← links)
- Neoadjuvant Pazopanib Treatment in High-Risk Soft Tissue Sarcoma: A Quantitative Dynamic 18F-FDG PET/CT Study of the German Interdisciplinary Sarcoma Group (Q92636272) (← links)
- Does Intravenous Contrast Improve the Diagnostic Yield of Fluorodeoxyglucose Positron-emission Tomography/Computed Tomography in Patients with Head-and-neck Malignancy (Q92712903) (← links)
- Noninvasive assessment and quantification of tumor vascularization using [18F]FDG-PET/CT and CE-CT in a tumor model with modifiable angiogenesis-an animal experimental prospective cohort study (Q92949892) (← links)